Workup of Cholelithiasis
Ultrasound is the first-line imaging test for suspected cholelithiasis with 96% accuracy for detecting gallstones, and should be performed in all patients with right upper quadrant pain to assess for gallstones and evaluate the biliary tree. 1
Initial Diagnostic Approach
Clinical Presentation
- Right upper quadrant pain (classic presentation)
- Referred pain to right supraclavicular region/shoulder
- Nausea and vomiting
- Positive Murphy's sign (tenderness on palpation of right upper quadrant during inspiration)
- Fever and elevated WBC may indicate complications like cholecystitis
Laboratory Testing
- Complete blood count
- Liver function tests (ALT, AST, bilirubin, ALP, GGT)
Imaging Algorithm
Step 1: Abdominal Ultrasound
- Gold standard initial test for cholelithiasis diagnosis 2
- Advantages:
- High accuracy (96%) for gallstone detection 1
- Can differentiate cholelithiasis from gallbladder sludge, polyps, or masses
- Non-invasive, portable, relatively inexpensive
- No radiation exposure
- Can evaluate intrahepatic and extrahepatic bile ducts
- Findings suggestive of cholelithiasis:
- Echogenic foci with acoustic shadowing in the gallbladder
- Gallbladder wall thickening (>3mm) may indicate cholecystitis
- Pericholecystic fluid (suggests inflammation)
- Sonographic Murphy sign (although specificity is limited) 1
Step 2: Further Imaging Based on Ultrasound Results
If Ultrasound is Positive for Gallstones:
- No further imaging needed if uncomplicated cholelithiasis
- If complications suspected (cholecystitis, choledocholithiasis):
- Assess risk for common bile duct stones using modified ASGE criteria 1:
- Very strong predictors: CBD stone on ultrasound, cholangitis, bilirubin >4 mg/dL
- Strong predictors: Dilated CBD on ultrasound (>6mm with gallbladder in situ), bilirubin 1.8-4 mg/dL
- Moderate predictors: Abnormal liver function tests, age >55, clinical gallstone pancreatitis
- Assess risk for common bile duct stones using modified ASGE criteria 1:
If High Risk for CBD Stones:
- Proceed directly to ERCP if CBD stone visualized on ultrasound 1
- Otherwise, consider MRCP, EUS, or intraoperative cholangiography 1
If Moderate Risk for CBD Stones:
- MRCP (sensitivity 85-100%, specificity 90%) 1, 3
- Endoscopic ultrasound (sensitivity 95%, specificity 97%) 1
- Choice depends on local expertise and availability
If Ultrasound is Negative or Equivocal but Suspicion Remains:
- CT abdomen with IV contrast
- MRI abdomen with MRCP
Management Considerations
Asymptomatic Cholelithiasis
- Generally managed with observation alone 5
- Only 10-25% of asymptomatic cases progress to symptomatic disease 5
Symptomatic Cholelithiasis
- Referral to surgeon and/or gastroenterologist within 2 weeks of initial presentation regardless of symptom severity 2
- Laparoscopic cholecystectomy for recurrent or severe symptoms
- Lifestyle and dietary modifications with possible gallstone dissolution agents for single symptomatic episode 2
Potential Pitfalls
- False positive ultrasound results (3.9%) - consider repeating suboptimal examinations 6
- False negative ultrasound results (2.3%) - may occur with small stones or thick-walled gallbladder 6
- Ultrasound limitations in critically ill patients where gallbladder abnormalities are common without acute cholecystitis 1
- CT has limited sensitivity for gallstones but better sensitivity for complications 4